NL-OMON29757尚未招募不适用
Radiolabeled bevacizumab as a tracer of VEGF expression in patients with colorectal liver metastases - Avastin-scanning in patients with colorectal liver metastases
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Colorectal liver metastases, planned surgical resection within 6 weeks.
排除标准
- •Pregnancy, lactation, recent chemotherapy (within 3 months after last chemotherapy regimen).
研究者
相似试验
尚未招募
不适用
Molecular imaging with radiolabeled bevacizumab in metastatic colon carcinoma; a feasibility study in patients who do not show response on bevacizumab therapy.10017990colon cancerNL-OMON31048niversitair Medisch Centrum Groningen6
已完成
不适用
Molecular imaging with radiolabeled bevacizumab in metastatic colon carcinoma. A feasibility study in patients who do show response on bevacizumab therapy10017990colon cancerNL-OMON30912niversitair Medisch Centrum Groningen6
进行中（未招募）
不适用
Evaluation of protein expression with labeled-bevacizumab scan in patients with relapsing multiple myeloma.EUCTR2012-002335-28-NLniversity medical centre groningen20
已完成
不适用
Evaluation of VEGF expression with 89Zr-bevacizumab PET scan in patients with relapsing multiple myeloma; a feasibility study.Multiple myeloma AND Kahler's disease1003522710005959NL-OMON37271niversitair Medisch Centrum Groningen20
已完成
不适用
89Zr-bevacizumab labelled PET imaging in patients with Renal Cell Carcinoma treated with sunitinib or bevacizumab plus interferon; a pilot studyNL-OMON33835niversitair Medisch Centrum Groningen26